Substance Use Disorders (SUD)Set & SettingPsilocybin

Magic Mushroom Use: A Qualitative Interview Study of Post-Trip Impacts and Strategies for Optimizing Experiences

This study (2022) used interviews to shed light on how people use magic mushrooms, what they perceive the effects of such use to be, and the meanings that users attach to their magic mushroom experiences. Participants associated magic mushroom use with lasting impacts on their lives including transformation and learning experiences. Furthermore, participants described strategies to optimize their magic mushroom experiences, including engaging in research regarding magic mushrooms as well as making use of peer support.

Authors

  • Shaw, L.
  • Rea, K.
  • Lachowsky, N. J.

Published

Journal of Psychoactive Drugs
individual Study

Abstract

The field of psychedelic research is undergoing a revival, yet research focused on non-clinical psychedelic use remains relatively limited. The current qualitative study sheds light on how people use magic mushrooms, what they perceive the effects of such use to be, and the meanings that users attach to their magic mushroom experiences. To be eligible to participate in the study, participants were required to be young adults who had used magic mushrooms within the past three months and residents of Victoria, Canada. Semi-structured, one-on-one in-person interviews regarding magic mushroom use habits, culture, knowledge and other factors were conducted with each participant and subsequently analyzed thematically. Participants associated magic mushroom use with lasting impacts on their lives including transformation and learning experiences. Additionally, participants described strategies to optimize their magic mushroom experiences, including engaging in research regarding magic mushrooms as well as making use of peer support. Furthermore, aspects of magic mushroom experiences conceptualized as harmful in previous studies were described by participants as associated with learning experiences and few harms. Participants’ perceived positive outcomes and relatively low-risk profile warrant further research to inform how magic mushroom users can maximize potential positive outcomes and also minimize harms.

Available with Blossom Pro

Research Summary of 'Magic Mushroom Use: A Qualitative Interview Study of Post-Trip Impacts and Strategies for Optimizing Experiences'

Introduction

Psychedelic research has entered a renewed period of activity often described as a "third wave," dominated by clinician-led, medicalised studies in neuroscience and therapeutic settings. Shaw and colleagues note that, despite growing clinical evidence, comparatively little research examines non‑clinical use of psychedelics—particularly magic mushrooms—that occurs outside of supervised or research settings. Existing non‑clinical literature tends to emphasise harms, often relies on surveys or online forum analyses, and therefore may underrepresent users' nuanced experiences and the meanings they attach to use. This study set out to address that gap by exploring how young adults in Greater Victoria, Canada, use magic mushrooms, what lasting effects they perceive, and what strategies they employ to optimise trips. The investigators aimed to expand knowledge of non‑clinical substance use practices and to highlight perceived post‑trip impacts and harm‑minimisation or optimisation strategies reported by users themselves.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Study Details

References (22)

Papers cited by this study that are also in Blossom

Harm potential of magic mushroom use: A review

Van Amsterdam, J., Opperhuizen, A., Van Den Brink, W. · Regulatory Toxicology and Pharmacology (2011)

169 cited
Psychedelics: Where we are now, why we got here, what we must do

Belouin, S. J., Henningfield, J. E. · Neuropharmacology (2018)

Self-reported negative outcomes of psilocybin users: A quantitative textual analysis

Bienemann, B., Ruschel, N. S., Campos, M. L. et al. · PLOS ONE (2020)

57 cited
Psychedelic pleasures: An affective understanding of the joys of tripping

Bøhling, F. · International Journal of Drug Policy (2017)

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Carhart-Harris, R. L., Bolstridge, M., Rucker, J. et al. · Lancet Psychiatry (2016)

1174 cited
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Carhart-Harris, R. L., Erritzoe, D., Williams, T. et al. · PNAS (2012)

Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin

Carhart-Harris, R. L., Leech, R., Williams, T. M. et al. · British Journal of Psychiatry (2018)

202 cited
Psychedelics and the essential importance of context

Carhart-Harris, R. L., Roseman, L., Haijen, E. C. H. M. et al. · Journal of Psychopharmacology (2018)

Ceremonial ‘Plant Medicine’ use and its relationship to recreational drug use: an exploratory study

Dorsen, C., Palamar, J., Shedlin, M. G. · Addiction Research and Theory (2018)

21 cited
Show all 22 references
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Psychopharmacology (2011)

Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population

Hendricks, P. S., Thorne, C. B., Clark, B. et al. · Journal of Psychopharmacology (2015)

345 cited
An online survey of tobacco smoking cessation associated with naturalistic psychedelic use

Johnson, M. W., Garcia-Romeu, A., Johnson, P. S. et al. · Journal of Psychopharmacology (2017)

117 cited
A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy

Luoma, J. B., Chwyl, C., Bathje, G. J. et al. · Journal of Psychoactive Drugs (2020)

168 cited
Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being

Mason, N. L., Mischler, E., Uthaug, M. V. et al. · Journal of Psychoactive Drugs (2019)

136 cited
Psychedelics as Medicines: An Emerging New Paradigm

Nichols, C. D., Nichols, D. E., Johnson, M. W. · Clinical Pharmacology and Therapeutics (2016)

A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamine

Palamar, J. J., Acosta, P. · Human Psychopharmacology (2020)

Why Psychiatry Needs Psychedelics and Psychedelics Need Psychiatry

Sessa, B. · Journal of Psychoactive Drugs (2014)

Cited By (4)

Papers in Blossom that reference this study

Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder

Weiss, B., Leor Roseman, •., Giribaldi, B. et al. · International Journal of Mental Health and Addiction (2024)

Perceptions of psychedelic personality change, determinants of use, setting and drug moderation: Toward a holistic model

Weiss, B., Sleep, C., Beller, N. et al. · Journal of Psychedelic Studies (2023)

10 cited
19 cited
Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020

Kopra, E., Ferris, J. A., Winstock, A. R. et al. · Journal of Psychopharmacology (2023)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.